Cellier et al. [1] first reported five cases in 2018, and described it as a relatively well-circumscribed neoplasm composed of atypical spindle and epithelioid cells immunoreactive for melanocytic markers, such as SOX10, MITF, and S100-protein; it was initially termed “cutaneous melanocytoma with CRTC1::TRIM11 fusion”. This evidence concerns the gene CRTC1 and neoplasm.